StockData

Indaptus Therapeutics, Inc. (INDP) stock

INDPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 5/30
$3.29−0.03 (-0.90%)

Close on Nov 18, 2026Market cap $438.37MP/E –Yield –

Indaptus Therapeutics free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Indaptus Therapeutics's free cash flow for the twelve months ending Dec 31, 2021 was -$11.29M. For fiscal 2021 it was -$11.29M.

Annual free cash flow

PeriodPeriod endValueChange
FY2021Dec 31, 2021-$11.29M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2021Dec 31, 2021-$3.54M–
Q3 FY2021Sep 30, 2021-$5.63M–

More Indaptus Therapeutics figures

See a number that looks wrong?